Abstract:Tobacco smoking causes DNA damages in epithelial cells and immune dysfunction in the lung, which collectively contribute to lung carcinogenesis and progression. However, potential mechanisms by which tumor-infiltrating immune cells contribute to lung cancer survival and their differential contributions in ever-smokers and never-smokers are not well studied. Here, we performed integrative analysis of 11 lung cancer gene-expression datasets, including 1,111 lung adenocarcinomas and 200 adjacent normal lung samples. Distinct pathways were altered in lung carcinogenesis in ever-smokers and never-smokers. Never-smoker patients had a better outcome than ever-smoker patients. We characterized compositional patterns of 21 types of immune cells in lung adenocarcinomas and revealed the complex association between immune cell composition and clinical outcomes. Interestingly, we found two subsets of immune cells, mast cells and CD4(+) memory T cells, which had completely opposite associations with outcomes in resting and activated status. We further discovered that several chemokines and their associated receptors (e.g., CXCL11-CX3CR1 axis) were selectively altered in lung tumors in response to cigarette smoking and their abundances showed stronger correlation with fractions of these immune subsets in ever-smokers than never-smokers. The status switched from the resting to activated forms in mast cells and CD4(+) memory T cells might manifest some important processes induced by cigarette smoking during tumor development and progression. Our findings suggested that aberrant activation of mast cells and CD4+ memory T cells plays crucial roles in cigarette smoking-induced immune dysfunction in the lung, which contributes to tumor development and progression.

Possible Oncogenic Viruses Associated with Lung Cancer

Epidermal Growth Factor Receptor Mutations Detected in Tumors from Chinese “never Smokers”with Lung Adenocarcinoma

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

Lung Cancer Models Reveal SARS-CoV-2-induced EMT Contributes to COVID-19 Pathophysiology

Prevention and management of lung cancer in China.

High-risk human papillomavirus infection in patients with lung cancer and its related mechanism

Tobacco and oral squamous cell carcinoma: A review of carcinogenic pathways

Etiology of lung cancer: Evidence from epidemiologic studies

Uncommon/rare oncogenic drivers in non‐small cell lung cancer: Consensus and contention

Smoker and non-smoker lung adenocarcinoma is characterized by distinct tumor immune microenvironments.

The emerging role of human papillomavirus in lung cancer

Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis.

Exploring the microbiome: Uncovering the link with lung cancer and implications for diagnosis and treatment

Risk factors for lung cancer worldwide

A review: cellular attachment and entry factors of human tumor-associated viruses

Lung cancer in patients who have never smoked — an emerging disease

Global research trends and hotspots on smoking and lung cancer from 1994-2023: A bibliometric analysis

Immunoregulatory Roles of Extracellular Vesicles and Associated Therapeutic Applications in Lung Cancer

Microbiology and Lung Cancer: A Comprehensive Review

Lung Cancer 2020: Epidemiology, Etiology, and Prevention

Treatment of lung cancer by acupuncture combined with medicine based on pathophysiological mechanism: A review